TARDBP and proteostasis deficiencies: Here, we will review the latest developments and outlooks of deriving TDP-43-specific biomarkers from: (1) pathophysiological processes involved in the development of TDP-43 proteinopathy, and (2) biofluid studies using biosamples from clinical entities associated with TDP-43 pathology.